EMAIL DIGESTS
Daily
Every morning
Weekly
Sunday recap
EpilepsyGTx is a biotechnology company developing gene therapies for focal refractory epilepsy. Their goal is to make patients with focal refractory epilepsy seizure-free.
EpilepsyGTx Raises $33M in Series A Funding
EpilepsyGTx Secures $33M Series A to Advance Gene Therapy for Epilepsy